Andrew R Shors, MD in Kalispell, MT - Medicare Dermatology

Andrew R Shors, MD is a medicare enrolled "Dermatology" physician in Kalispell, Montana. He went to University Of Washington School Of Medicine and graduated in 2000 and has 24 years of diverse experience with area of expertise as Dermatology. He is a member of the group practice Highline Dermatology And Skin Cancer, Pc and his current practice location is 60 Four Mile Drive Ste 11, Kalispell, Montana. You can reach out to his office (for appointments etc.) via phone at (406) 314-4788.

Andrew R Shors is licensed to practice in Montana (license number 49148) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1669552659.

Contact Information

	Andrew R Shors, MD
	60 Four Mile Drive Ste 11, Kalispell, MT 59901-2663
	(406) 314-4788
	Not Available

Physician's Profile

Full Name	Andrew R Shors
Gender	Male
Speciality	Dermatology
Experience	24 Years
Location	60 Four Mile Drive Ste 11, Kalispell, Montana
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Andrew R Shors attended and graduated from University Of Washington School Of Medicine in 2000

NPI Data:

NPI Number: 1669552659
Provider Enumeration Date: 10/16/2006
Last Update Date: 09/28/2020

Medicare PECOS Information:

PECOS PAC ID: 3678556131
Enrollment ID: I20160721001965

Medical Identifiers

Medical identifiers for Andrew R Shors such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1669552659	NPI	-	NPPES
8387995	Medicaid	WA
194630	Other		INTERNAL ID-MOTOR VEHICLE ID

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207ND0101X	Dermatology - Mohs-micrographic Surgery	49148 (Montana)	Secondary
207N00000X	Dermatology	49148 (Montana)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Kalispell Regional Medical Center	Kalispell, MT	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Highline Dermatology And Skin Cancer, Pc	0749529055	3

News Archive

Future lung cancer screening strategies should address equity, implementation issues, say experts

Calling the U.S. Preventive Services Task Force's newly released recommendation statement to expand eligibility for annual lung cancer screening with low-dose computed tomography a step forward, UNC Lineberger Comprehensive Cancer Center researchers say future changes should address equity and implementation issues.

Amylin files lawsuit against Eli Lilly for improper commercialization of exenatide

Amylin Pharmaceuticals, Inc. today announced that it has filed a lawsuit against Eli Lilly and Company in the United States District Court for the Southern District of California, alleging that Lilly is engaging in anticompetitive activity and breaching its strategic alliance agreements with Amylin to maximize commercialization of exenatide.

AcelRx Pharmaceuticals completes End-of-Phase 2 meeting with the FDA for its ARX-01drug/device

AcelRx Pharmaceuticals, Inc. today announced that it has successfully completed an End-of-Phase 2 meeting with the FDA for ARX-01, a drug/device combination product based on the company's proprietary NanoTab(TM) dosage form, which enables delivery of sufentanil by the non-invasive oral transmucosal (sublingual) route.

AusBiotech, WMDO to offer online medtech courses

WMDO, the leading global provider of innovative online training for medical device professionals, and AusBiotech, Australia's leading biotechnology industry organization, announced today a strategic partnership that offers AusBiotech Members access to WMDO's professional online training.

Lotus fiscal year revenue increases 28.7% to $72.7 million for 2010

Lotus Pharmaceuticals, Inc., a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2010.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Andrew R Shors allows following entities to bill medicare on his behalf.

Entity Name	Highline Dermatology And Skin Cancer, Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1558831289 PECOS PAC ID: 0749529055 Enrollment ID: O20190305000502

News Archive

Future lung cancer screening strategies should address equity, implementation issues, say experts

Amylin files lawsuit against Eli Lilly for improper commercialization of exenatide

AcelRx Pharmaceuticals completes End-of-Phase 2 meeting with the FDA for its ARX-01drug/device

AusBiotech, WMDO to offer online medtech courses

Lotus fiscal year revenue increases 28.7% to $72.7 million for 2010

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Andrew R Shors is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Andrew R Shors, MD 40 Four Mile Drive, Ste 7, Kalispell, MT 59901-2655 Ph: (406) 314-4788	Andrew R Shors, MD 60 Four Mile Drive Ste 11, Kalispell, MT 59901-2663 Ph: (406) 314-4788

News Archive

Future lung cancer screening strategies should address equity, implementation issues, say experts

Amylin files lawsuit against Eli Lilly for improper commercialization of exenatide

AcelRx Pharmaceuticals completes End-of-Phase 2 meeting with the FDA for its ARX-01drug/device

AusBiotech, WMDO to offer online medtech courses

Lotus fiscal year revenue increases 28.7% to $72.7 million for 2010

Dermatology Doctors in Kalispell, MT

George W Mclean, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 210 Sunnyview Ln, Ste 105, Kalispell, MT 59901 Phone: 406-752-7927 Fax: 406-752-3458
Ann Chang Brewer, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 175 Commons Loop Ste 300, Kalispell, MT 59901 Phone: 406-756-7555
Mr. Peter Ashton Young, PA-C Dermatology Medicare: Medicare Enrolled Practice Location: 40 Four Mile Dr Ste 7, Kalispell, MT 59901 Phone: 406-314-6336
David K Murdock, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 175 Commons Loop, Ste 300, Kalispell, MT 59901 Phone: 406-756-7555 Fax: 406-756-7517
Thomas F George, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 175 Commons Loop, Ste 300, Kalispell, MT 59901 Phone: 406-756-7555 Fax: 406-756-7517
Sylvia A Owen, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 40 Four Mile Dr Ste 7, Kalispell, MT 59901 Phone: 406-314-6336 Fax: 406-890-6711

Andrew R Shors, MD - Medicare Dermatology in Kalispell, MT

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Future lung cancer screening strategies should address equity, implementation issues, say experts

Amylin files lawsuit against Eli Lilly for improper commercialization of exenatide

AcelRx Pharmaceuticals completes End-of-Phase 2 meeting with the FDA for its ARX-01drug/device

AusBiotech, WMDO to offer online medtech courses

Lotus fiscal year revenue increases 28.7% to $72.7 million for 2010

Medicare Reassignments

Future lung cancer screening strategies should address equity, implementation issues, say experts

Amylin files lawsuit against Eli Lilly for improper commercialization of exenatide

AcelRx Pharmaceuticals completes End-of-Phase 2 meeting with the FDA for its ARX-01drug/device

AusBiotech, WMDO to offer online medtech courses

Lotus fiscal year revenue increases 28.7% to $72.7 million for 2010

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Future lung cancer screening strategies should address equity, implementation issues, say experts

Amylin files lawsuit against Eli Lilly for improper commercialization of exenatide

AcelRx Pharmaceuticals completes End-of-Phase 2 meeting with the FDA for its ARX-01drug/device

AusBiotech, WMDO to offer online medtech courses

Lotus fiscal year revenue increases 28.7% to $72.7 million for 2010

Dermatology Doctors in Kalispell, MT